Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice

Journal of Immunology

Volumn 166, Issue 11, 2001, Pages 6820-6828

  Robson, Michael G ^a   Cook, H Terence ^a   Botto, Marina ^a   Taylor, Philip R ^a   Busso, Nathalie ^b   Salvi, Roberto ^b   Pusey, Charles D ^a   Walport, Mark J ^a   Davies, Kevin A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; CREATININE; IMMUNOGLOBULIN G; PROCOAGULANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; DISEASE EXACERBATION; GENE EXPRESSION; GLOMERULOSCLEROSIS; IMMUNE COMPLEX NEPHRITIS; IMMUNE RESPONSE; IMMUNOGLOBULIN DEPOSITION; LEUKOCYTE COUNT; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0035338308     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.11.6820     Document Type: Article

References (45)

1. Baker, P. J., R. F. Ochi, M. Schulze, R. J. Johnson, C. Campbell, and W. G. Couser. 1989. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am. J. Pathol. 135:185.
2. Cochrane, C. G., E. R. Unanue, and F. J. Dixon. 1965. A role of polymorpho-nuclear leukocytes and complement in nephrotoxic nephritis. J. Exp. Med. 122: 99.
3. Couser, W. G., R. J. Johnson, B. A. Young, C. G. Yeh, C. A. Toth, and A. R. Rudolph. 1995. The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J. Am. Soc. Nephrol. 5:1888.
4. Groggel, G. C., S. Adler, H. G. Rennke, W. G. Couser, and D. J. Salant. 1983. Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J. Clin. Invest. 72:1948.
5. Groggel, G. C., D. J. Salant, C. Darby, H. G. Rennke, and W. G. Couser. 1985. Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis. Kidney Int. 27:643.
6. Leenaerts, P. L., B. M. Hall, B. J. Van Damme, M. R. Daha, and Y. F. Vanrenterghem. 1995. Active Heymann nephritis in complement component C6 deficient rats. Kidney Int. 47:1604.
7. Matsuo, S., H. Nishikage, F. Yoshida, A. Nomura, S. J. Piddlesden, and B. P. Morgan. 1994. Role of CD59 in experimental glomerulonephritis in rats. Kidney Int. 46:191.
8. Salant, D. J., S. Belok, M. P. Madaio, and W. G. Couser. 1980. A new role for complement in experimental membranous nephropathy in rats J. Clin. Invest. 66:1339.
9. Brandt, J., J. Pippin, M. Sculze, G. M. Hansch, C. E., Alpers, R. J. Johnson, K. Gordon, and W. G. Couser. 1996. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int. 49:335.
10. Cybulsky, A. V., H. G. Rennke, I. D. Feintzeig, and D. J. Salant. 1985. Complement-induced glomerular epithelial cell injury: role of the membrane attack complex in rat membranous nephropathy. J. Clin. Invest. 77:1096.
11. Pickering, M. C., M. Botto, P. R. Taylor, P. J. Lachmann, and M. J. Walport. 2000. Systemic lupus erythematosus, complement deficiency and apoptosis. Adv. Immunol. 76:227.
12. Davies, K. A., A. M. Peters, H. L. Beynon, and M. J. Walport. 1992. Immune complex processing in patients with systemic lupus erythematosus: in vivo imaging and clearance studies. J. Clin. Invest. 90:2075.
13. Davies, K. A., K. Erlendsson, H. L. Beynon, A. M. Peters, K. Steinsson, H. Valdimarsson, and M. J. Walport. 1993. Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151:3866.
14. Korb, L. C., and J. M. Ahearn. 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158:4525.
15. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56.
16. Taylor, P. R., A. Carugati, V. A. Fadock, H. T. Cook, M. Andrews, M. C. Carroll, J. S. Savill, P. M. Henson, M. Botto, and M. J. Walport. 2000. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells. J. Exp. Med. 192:359.
17. Huang, X. R., S. R. Holdsworth, and P. G. Tipping. 1997. Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J. Am. Soc. Nephrol. 8:1101.
18. Taylor, P. R., J. T. Nash, E. Theodoridis, A. E. Bygrave, M. J. Walport, and M. Botto. 1998. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J. Biol. Chem. 273:1699.
19. Mitchell, D. A., P. R. Taylor, H. T. Cook, J. Moss, A. E. Bygrave, M. J. Walport, and M. Botto. 1999. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J. Immunol. 162:5676.
20. Busso, N., V. Peclat, K. Van Ness, E. Kolodziesczyk, J. Degen, T. Bugge, and A. So. 1998. Exacerbation of antigen-induced arthritis in urokinase-deticient mice. J. Clin. Invest. 102:41.
21. Belin, D. 1998. The use of RNA probes for the analysis of gene expression. Northern blot hybridization and ribonuclease protection assay. Methods Mol. Biol. 86:87.
22. Chen, Z., S. B. Koralov, and G. Kelsoe. 2000. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192:1339.
23. Herbert, M., T. Takano, P. A., H. G. Rennke, A. Minto, D. J. Salant, M. C. Carroll, and H. R. Brady. 1998. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol. Dial. Transplant. 13:2799.
24. Tang, T., A. Rosenkranz, K. J. M. Assmann, M. J. Goodman, J. C. Gutierrez Ramos, M. C. Carroll, R. S. Cotran, and T. N. Mayadas. 1997. A role for Mac-1 (CD11b/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcγ receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 186:1853.
25. Sheerin, N. S., T. Springall, M. C. Carroll, B. Hartley, and S. H. Sacks. 1997. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3-and C4-deficient mice. Clin. Exp. Immunol. 110:403.
26. Tipping, P. G., X. R. Huang, M. C. Berndt, and S. R. Holdsworth. 1994. A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int. 46:79.
27. Schrijver, G., K. J. Assmann, M. J. Bogman, J. C. Robben, R. M. de Waal, and R. A. Koene. 1988. Antiglomerular basement membrane nephritis in the mouse. Study on the role of complement in the heterologous phase. Lab. Invest. 59:484.
28. Cutler, A. J. M. Botto, D. van Essen, R. Rivi, K. A. Davies, D. Gray, and M. J. Walport. 1998. T cell-dependent immune response in C1q-deficient mice: defective interferon γ production by antigen-specific T cells. J. Exp. Med. 187: 1789.
29. Takahashi, M., B. F. Tack, and V. Nussenzweig. 1977. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. J. Exp. Med. 145:86.
30. Volanakis, J. E. 1982. Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide. J. Immunol. 128:2745.
31. Spath, P. J., M. Pascual, L. Meyer-Hanni, U. B. Schaad, and J. A. Schifferli. 1988. Solubilization of immune precipitates by complement in the absence of properdin or factor D. FEBS Lett. 234:131.
32. Park, S. Y., S. Ueda, H. Ohno, S. Tanaka, T. Shiratori, T. Yamazaki, H. Arase, A. Karasawa, S. Sato, B. Ledernann, et al. 1998. Resistance of Fc receptor deficient mice to fatal glomerulonephritis. J. Clin. Invest. 102:1229.
33. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052.
34. Sylvestre, D., R. Clynes, M. Ma, H. Warren, M. C. Carroll, and J. V. Ravetch. 1996. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J. Exp. Med. 184:2385.
35. Hazenbos, W. L., J. E. Gessner, F. M. Hofhuis, H. Kuipers, D. Meyer, I. A. Heijnen, R. E. Schmidt, M. Sandor, P. J. Capel, M. Daeron, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity. 5:181.
36. Heller, T., J. E. Gessner, R. E. Schmidt, A. Klos, W. Bautsch, and J. Kohl. 1999. Cutting edge: Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis. J. Immunol. 162:5657.
37. Hopken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1997. Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186:749.
38. Bozic, C. R., B. Lu, U. E. Hopken, C. Gerard, and N. P. Gerard. 1996. Neurogenic amplification of immune complex inflammation. Science 273:1722.
39. Mevorach, D., J. O. Mascarenhas, D. Gershov, and K. B. Elkon. 1998. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188:2313.
40. Casciola-Rosen, L., A. Rosen, M. Petri, and M. Schlissel. 1996. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93:1624.
41. Tipping, P. G., M. G. Lowe, and S. R. Holdsworth. 1988. Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits. J. Clin. Invest. 82:1253.
42. Tipping, P. G., J. H. Erlich, J. Apostolopoulos, N. Mackman, D. Loskutoff, and S. R. Holdsworth. 1995. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am. J. Pathol. 147:1736.
43. Tipping, P. G., J. P. Dowling, and S. R. Holdsworth. 1988. Glomerular procoagulant activity in human proliferative glomerulonephritis. J. Clin. Invest. 81: 119.
44. Sappino, A. P., J. Huarte, J. D. Vassalli, and D. Belin. 1991. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J. Clin. Invest. 87:962.
45. Kitching, A. R., S. R. Holdsworth, V. A. Ploplis, E. F. Plow, D. Collen, P. Carmeliet, and P. G. Tipping. 1997. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J. Exp. Med. 185:963.